BioCentury | Nov 20, 2020
Finance

SR One’s newfound freedom allows firm to increase focus on company creation

SR One’s spinout from GSK gives the newly independent VC the ability to scale up what has been a top-tier investment firm over the past decade, along with the freedom to take larger stakes...
BioCentury | Oct 15, 2020
Politics, Policy & Law

U.K. joining regulatory consortium as Brexit deadline looms

...sign that MHRA is preparing for its newfound...
BioCentury | Feb 10, 2018
Financial News

Biotech index gains erased, fund flows into the red

...increases did little to reverse the losses seen over two extremely volatile weeks caused by newfound...
BioCentury | Oct 6, 2017
Finance

High as a Kite

...who cashed out prior to the Oct. 3 deal close have already started putting their newfound...
...who cashed out prior to the Oct. 3 deal close have already started putting their newfound...
BioCentury | Jul 7, 2017
Finance

Generalists needed

...bolus of cash from the J&J deal, and he suspects many have already put their newfound...
BioCentury | Oct 13, 2016
Strategy

Exosomes in the zone

...full speed, as it grapples with CMC hurdles such scale-up, consistency and efficient purification. The newfound...
BioCentury | Sep 23, 2013
Strategy

Deal sense at Isis

...CRPC) and non-small cell lung cancer (NSCLC). Preferred partnerships Those experiences, along with the company's newfound...
BioCentury | Jun 18, 2009
Tools & Techniques

A first for monkey models

...Embryonic stem cells are routinely used to produce transgenic mice. Where to start With the newfound...
BioCentury | Feb 14, 2008
Targets & Mechanisms

Cancerous RAGE

...into practical therapies is part of a bigger picture. "If you take all of this newfound...
BioCentury | Dec 24, 2007
Strategy

One deal, many MOR antibodies

...and will require a very large and expensive Phase III trial," Moroney said. With his newfound...
Items per page:
1 - 10 of 14
BioCentury | Nov 20, 2020
Finance

SR One’s newfound freedom allows firm to increase focus on company creation

SR One’s spinout from GSK gives the newly independent VC the ability to scale up what has been a top-tier investment firm over the past decade, along with the freedom to take larger stakes...
BioCentury | Oct 15, 2020
Politics, Policy & Law

U.K. joining regulatory consortium as Brexit deadline looms

...sign that MHRA is preparing for its newfound...
BioCentury | Feb 10, 2018
Financial News

Biotech index gains erased, fund flows into the red

...increases did little to reverse the losses seen over two extremely volatile weeks caused by newfound...
BioCentury | Oct 6, 2017
Finance

High as a Kite

...who cashed out prior to the Oct. 3 deal close have already started putting their newfound...
...who cashed out prior to the Oct. 3 deal close have already started putting their newfound...
BioCentury | Jul 7, 2017
Finance

Generalists needed

...bolus of cash from the J&J deal, and he suspects many have already put their newfound...
BioCentury | Oct 13, 2016
Strategy

Exosomes in the zone

...full speed, as it grapples with CMC hurdles such scale-up, consistency and efficient purification. The newfound...
BioCentury | Sep 23, 2013
Strategy

Deal sense at Isis

...CRPC) and non-small cell lung cancer (NSCLC). Preferred partnerships Those experiences, along with the company's newfound...
BioCentury | Jun 18, 2009
Tools & Techniques

A first for monkey models

...Embryonic stem cells are routinely used to produce transgenic mice. Where to start With the newfound...
BioCentury | Feb 14, 2008
Targets & Mechanisms

Cancerous RAGE

...into practical therapies is part of a bigger picture. "If you take all of this newfound...
BioCentury | Dec 24, 2007
Strategy

One deal, many MOR antibodies

...and will require a very large and expensive Phase III trial," Moroney said. With his newfound...
Items per page:
1 - 10 of 14